Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-utility of an eHealth application 'Oncokompas' that supports cancer survivors in self-management: results of a randomised controlled trial.
van der Hout A, Jansen F, van Uden-Kraan CF, Coupé VM, Holtmaat K, Nieuwenhuijzen GA, Hardillo JA, de Jong RJB, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RJE, Bosscha K, van den Brekel MWM, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek WT, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM. van der Hout A, et al. Among authors: nieuwenhuijzen ga. J Cancer Surviv. 2021 Feb;15(1):77-86. doi: 10.1007/s11764-020-00912-9. Epub 2020 Jul 12. J Cancer Surviv. 2021. PMID: 32656739 Free PMC article. Clinical Trial.
Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands.
Sukel MP, van de Poll-Franse LV, Nieuwenhuijzen GA, Vreugdenhil G, Herings RM, Coebergh JW, Voogd AC. Sukel MP, et al. Among authors: nieuwenhuijzen ga. Eur J Cancer. 2008 Sep;44(13):1846-54. doi: 10.1016/j.ejca.2008.06.001. Epub 2008 Jul 17. Eur J Cancer. 2008. PMID: 18640030
Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis.
van Herk-Sukel MP, van de Poll-Franse LV, Voogd AC, Nieuwenhuijzen GA, Coebergh JW, Herings RM. van Herk-Sukel MP, et al. Among authors: nieuwenhuijzen ga. Breast Cancer Res Treat. 2010 Aug;122(3):843-51. doi: 10.1007/s10549-009-0724-3. Epub 2010 Jan 8. Breast Cancer Res Treat. 2010. PMID: 20058066
357 results